Coated oral 5-aminosalicylic acid versus placebo in maintaining remission of inactive Crohn's disease

Alimentary Pharmacology and Therapeutics

Volumn 4, Issue 1, 1990, Pages 55-64

  Thomson, A B R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MESALAZINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DRUG COATING; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

EID: 0025293586     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.1990.tb00449.x     Document Type: Article

References (23)

1. Summers National Cooperative Crohn's Disease Study: results of drug treatment Gastro-enterology 1979 10.1016/0016-5085(79)90385-8 77 847
2. Singleton A trial of sulfasalazine as adjunctive therapy of Crohn's disease Gastroenterology 1979 10.1016/0016-5085(79)90388-3 77 887
3. Malchow European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment Gastroenterology 1984 10.1016/0016-5085(84)90409-8 86 249
4. Ursing A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the Cooperative Crohn's Disease Study in Sweden. II. Results Gastroenterology 1982 10.1016/S0016-5085(82)80189-3 83 550
5. O'Donoghue Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease Lancet 1978 10.1016/S0140-6736(78)92524-2 ii 955
6. Imes Effect of Ensure, a defined formula diet in patients with Crohn's disease Digestion 1986 10.1159/000199362 35 158
7. Imes Diet counselling improves the clinical course of patients with Crohn's disease Digestion 1988 10.1159/000199602 39 7
8. O'Morain Elemental diet as primary treatment of acute Crohn's disease: a controlled trial Br Med J 1984 10.1136/bmj.288.6434.1859 288 1859
9. Saverymuttu Controlled trial comparing prednisone with an elemental diet plus non-absorbable antibiotics in active Crohn's disease Gut 1985 10.1136/gut.26.10.994 26 994
10. Klotz Therapeutic efficacy of sulphasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease N Engl J Med 1980 10.1056/NEJM198012253032602 303 499
11. Khan An experiment to determine the active therapeutic moiety of sulphasalazine Lancet 1977 10.1016/S0140-6736(77)90831-5 ii 892
12. Khan Circulating levels of sulphasalazine and its metabolites and their relation to the critical efficacy of the drug on ulcerative colitis Gut 1980 10.1136/gut.21.8.706 21 706
13. Das Adverse reaction during salicyl-azosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype N Engl J Med 1973 10.1056/NEJM197309062891001 289 491
14. Rasmussen 5-aminosalicylic acid in the treatment of Crohn's disease Scand J Gastroenterology 1987 10.3109/00365528708991929 22 877
15. Schroeder Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis N Engl J Med 1987 10.1056/NEJM198712243172603 26 1625
16. Sandberg-Gertzen Azodisal sodium in the treatment of ulcerative colitis Gastroenterology 1986 10.1016/0016-5085(86)90882-6 90 1024
17. Hardy Evaluation of an enteric-coated delayed-release 5-aminosalicylic acid tablet in patients with inflammatory bowel disease Aliment Pharmacol Therap 1987 10.1111/j.1365-2036.1987.tb00627.x 1 273
18. Rachmilewitz Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial Br Med J 1989 10.1136/bmj.298.6666.82 298 82
19. Rutgeerts Comparable efficacy of coated, oral 5-aminosalicylic acid, Claversal* and sulfasalazine for maintaining remission of ulcerative colitis Aliment Pharmacol Therap 1989 10.1111/j.1365-2036.1989.tb00204.x 3 183
20. Dissanayake A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine (Salazopyrin) Gut 1973 10.1136/gut.14.12.923 14 923
21. Dick A controlled trial of sulphasalazine in treatment of ulcerative colitis Gut 1964 10.1136/gut.5.5.437 5 437
22. Sharon Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease Gastroenterology 1984 10.1016/S0016-5085(84)80015-3 86 453
23. Brignola Importance of laboratory parameters in the evaluation of Crohn's disease activity J Clin Gastroenterol 1986 10.1097/00004836-198606000-00008 9 245